Browsing by Author "Wu, Peitao"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Impact of Rare and Common Genetic Variants on Diabetes Diagnosis by Hemoglobin A1c in Multi-Ancestry Cohorts: The Trans-Omics for Precision Medicine Program
    (Elsevier, 2019-09-26) Sarnowski, Chloé; Leong, Aaron; Raffield, Laura M.; Wu, Peitao; de Vries, Paul S.; DiCorpo, Daniel; Guo, Xiuqing; Xu, Huichun; Liu, Yongmei; Zheng, Xiuwen; Hu, Yao; Brody, Jennifer A.; Goodarzi, Mark O.; Hidalgo, Bertha A.; Highland, Heather M.; Jain, Deepti; Liu, Ching-Ti; Naik, Rakhi P.; O’Connell, Jeffrey R.; Perry, James A.; Porneala, Bianca C.; Selvin, Elizabeth; Wessel, Jennifer; Psaty, Bruce M.; Curran, Joanne E.; Peralta, Juan M.; Blangero, John; Kooperberg, Charles; Mathias, Rasika; Johnson, Andrew D.; Reiner, Alexander P.; Mitchell, Braxton D.; Cupples, L. Adrienne; Vasan, Ramachandran S.; Correa, Adolfo; Morrison, Alanna C.; Boerwinkle, Eric; Rotter, Jerome I.; Rich, Stephen S.; Manning, Alisa K.; Dupuis, Josée; Meigs, James B.; TOPMed Diabetes Working Group; TOPMed Hematology Working Group; TOPMed Hemostasis Working Group; National Heart, Lung, and Blood Institute TOPMed Consortium; Epidemiology, School of Public Health
    Hemoglobin A1c (HbA1c) is widely used to diagnose diabetes and assess glycemic control in individuals with diabetes. However, nonglycemic determinants, including genetic variation, may influence how accurately HbA1c reflects underlying glycemia. Analyzing the NHLBI Trans-Omics for Precision Medicine (TOPMed) sequence data in 10,338 individuals from five studies and four ancestries (6,158 Europeans, 3,123 African-Americans, 650 Hispanics, and 407 East Asians), we confirmed five regions associated with HbA1c (GCK in Europeans and African-Americans, HK1 in Europeans and Hispanics, FN3K and/or FN3KRP in Europeans, and G6PD in African-Americans and Hispanics) and we identified an African-ancestry-specific low-frequency variant (rs1039215 in HBG2 and HBE1, minor allele frequency (MAF) = 0.03). The most associated G6PD variant (rs1050828-T, p.Val98Met, MAF = 12% in African-Americans, MAF = 2% in Hispanics) lowered HbA1c (−0.88% in hemizygous males, −0.34% in heterozygous females) and explained 23% of HbA1c variance in African-Americans and 4% in Hispanics. Additionally, we identified a rare distinct G6PD coding variant (rs76723693, p.Leu353Pro, MAF = 0.5%; −0.98% in hemizygous males, −0.46% in heterozygous females) and detected significant association with HbA1c when aggregating rare missense variants in G6PD. We observed similar magnitude and direction of effects for rs1039215 (HBG2) and rs76723693 (G6PD) in the two largest TOPMed African American cohorts, and we replicated the rs76723693 association in the UK Biobank African-ancestry participants. These variants in G6PD and HBG2 were monomorphic in the European and Asian samples. African or Hispanic ancestry individuals carrying G6PD variants may be underdiagnosed for diabetes when screened with HbA1c. Thus, assessment of these variants should be considered for incorporation into precision medicine approaches for diabetes diagnosis.
  • Thumbnail Image
    Item
    Whole Genome Sequence Association Analysis of Fasting Glucose and Fasting Insulin Levels in Diverse Cohorts from the NHLBI TOPMed Program
    (Springer Nature, 2022-07-28) DiCorpo, Daniel; Gaynor, Sheila M.; Russell, Emily M.; Westerman, Kenneth E.; Raffield, Laura M.; Majarian, Timothy D.; Wu, Peitao; Sarnowski, Chloé; Highland, Heather M.; Jackson, Anne; Hasbani, Natalie R.; de Vries, Paul S.; Brody, Jennifer A.; Hidalgo, Bertha; Guo, Xiuqing; Perry, James A.; O’Connell, Jeffrey R.; Lent, Samantha; Montasser, May E.; Cade, Brian E.; Jain, Deepti; Wang, Heming; D’Oliveira Albanus, Ricardo; Varshney, Arushi; Yanek, Lisa R.; Lange, Leslie; Palmer, Nicholette D.; Almeida, Marcio; Peralta, Juan M.; Aslibekyan, Stella; Baldridge, Abigail S.; Bertoni, Alain G.; Bielak, Lawrence F.; Chen, Chung-Shiuan; Chen, Yii-Der Ida; Choi, Won Jung; Goodarzi, Mark O.; Floyd, James S.; Irvin, Marguerite R.; Kalyani, Rita R.; Kelly, Tanika N.; Lee, Seonwook; Liu, Ching-Ti; Loesch, Douglas; Manson, JoAnn E.; Minster, Ryan L.; Naseri, Take; Pankow, James S.; Rasmussen-Torvik, Laura J.; Reiner, Alexander P.; Reupena, Muagututi’a Sefuiva; Selvin, Elizabeth; Smith, Jennifer A.; Weeks, Daniel E.; Xu, Huichun; Yao, Jie; Zhao, Wei; Parker, Stephen; Alonso, Alvaro; Arnett, Donna K.; Blangero, John; Boerwinkle, Eric; Correa, Adolfo; Cupples, L. Adrienne; Curran, Joanne E.; Duggirala, Ravindranath; He, Jiang; Heckbert, Susan R.; Kardia, Sharon L.R.; Kim, Ryan W.; Kooperberg, Charles; Liu, Simin; Mathias, Rasika A.; McGarvey, Stephen T.; Mitchell, Braxton D.; Morrison, Alanna C.; Peyser, Patricia A.; Psaty, Bruce M.; Redline, Susan; Shuldiner, Alan R.; Taylor, Kent D.; Vasan, Ramachandran S.; Viaud-Martinez, Karine A.; Florez, Jose C.; Wilson, James G.; Sladek, Robert; Rich, Stephen S.; Rotter, Jerome I.; Lin, Xihong; Dupuis, Josée; Meigs, James B.; Wessel, Jennifer; Manning, Alisa K.; Epidemiology, School of Public Health
    The genetic determinants of fasting glucose (FG) and fasting insulin (FI) have been studied mostly through genome arrays, resulting in over 100 associated variants. We extended this work with high-coverage whole genome sequencing analyses from fifteen cohorts in NHLBI's Trans-Omics for Precision Medicine (TOPMed) program. Over 23,000 non-diabetic individuals from five race-ethnicities/populations (African, Asian, European, Hispanic and Samoan) were included. Eight variants were significantly associated with FG or FI across previously identified regions MTNR1B, G6PC2, GCK, GCKR and FOXA2. We additionally characterize suggestive associations with FG or FI near previously identified SLC30A8, TCF7L2, and ADCY5 regions as well as APOB, PTPRT, and ROBO1. Functional annotation resources including the Diabetes Epigenome Atlas were compiled for each signal (chromatin states, annotation principal components, and others) to elucidate variant-to-function hypotheses. We provide a catalog of nucleotide-resolution genomic variation spanning intergenic and intronic regions creating a foundation for future sequencing-based investigations of glycemic traits.